These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12173338)

  • 21. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
    Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic pathways to glioblastoma: a population-based study.
    Ohgaki H; Dessen P; Jourde B; Horstmann S; Nishikawa T; Di Patre PL; Burkhard C; Schüler D; Probst-Hensch NM; Maiorka PC; Baeza N; Pisani P; Yonekawa Y; Yasargil MG; Lütolf UM; Kleihues P
    Cancer Res; 2004 Oct; 64(19):6892-9. PubMed ID: 15466178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N; Jaafart H; Isa MN; Abdullah JM
    Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic alterations in pediatric high-grade astrocytomas.
    Cheng Y; Ng HK; Zhang SF; Ding M; Pang JC; Zheng J; Poon WS
    Hum Pathol; 1999 Nov; 30(11):1284-90. PubMed ID: 10571506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas.
    Willert JR; Daneshvar L; Sheffield VC; Cogen PH
    Genes Chromosomes Cancer; 1995 Mar; 12(3):165-72. PubMed ID: 7536455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of genomic abnormalities in human gliomas.
    Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Cancer Genet Cytogenet; 1994 Apr; 73(2):122-9. PubMed ID: 8174086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
    Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N
    Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.
    Hoang-Xuan K; He J; Huguet S; Mokhtari K; Marie Y; Kujas M; Leuraud P; Capelle L; Delattre JY; Poirier J; Broët P; Sanson M
    Neurology; 2001 Oct; 57(7):1278-81. PubMed ID: 11591848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.
    Ransom DT; Ritland SR; Moertel CA; Dahl RJ; O'Fallon JR; Scheithauer BW; Kimmel DW; Kelly PJ; Olopade OI; Diaz MO
    Genes Chromosomes Cancer; 1992 Nov; 5(4):357-74. PubMed ID: 1283325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
    Brat DJ; Seiferheld WF; Perry A; Hammond EH; Murray KJ; Schulsinger AR; Mehta MP; Curran WJ;
    Neuro Oncol; 2004 Apr; 6(2):96-103. PubMed ID: 15134623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progression-associated gene regions in astrocytomas: a candidate locus on chromosome 19q].
    von Deimling A; Albrecht S; Wiestler OD
    Verh Dtsch Ges Pathol; 1994; 78():423-6. PubMed ID: 7534013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.
    Fujisawa H; Reis RM; Nakamura M; Colella S; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 2000 Jan; 80(1):65-72. PubMed ID: 10653004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of heterozygosity on chromosome 19 in secondary glioblastomas.
    Nakamura M; Yang F; Fujisawa H; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 2000 Jun; 59(6):539-43. PubMed ID: 10850866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas.
    Arslantas A; Artan S; Oner U; Müslümanoglu MH; Ozdemir M; Durmaz R; Arslantas D; Vural M; Cosan E; Atasoy MA
    Pathol Oncol Res; 2007; 13(1):39-46. PubMed ID: 17387387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome.
    Motomura K; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nakazato Y; Tanaka Y; Pierscianek D; Kim YH; Mariani L; Vital A; Ohgaki H
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):702-7. PubMed ID: 22805772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
    Kaulich K; Blaschke B; Nümann A; von Deimling A; Wiestler OD; Weber RG; Reifenberger G
    J Neuropathol Exp Neurol; 2002 Dec; 61(12):1092-9. PubMed ID: 12484572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.